InnoCell™

• High oxygen permeability: Enables efficient oxygen supply to cells and tissues, supporting healthier and longer-term cultures. 

• Enhanced cell viability: Reduces cell death in complex 3D cultures such as spheroids and organoids. 

• Improved assay reliability: Supports more predictive in vitro testing environments for drug discovery applications. 

• Low drug adsorption: Minimizes compound loss and improves accuracy in pharmaceutical screening. 

• Excellent imaging performance: Provides high resolution and low autofluorescence for advanced imaging techniques such as high-content screening.

InnoCell™ is built on the synergy of Mitsui Chemicals’ proprietary materials and precision processing technologies.

This unique combination enables the creation of microplates with superior oxygen permeability while maintaining excellent optical and chemical properties required for modern cell culture and analytical workflows.

InnoCell™ has demonstrated improved proliferation of patient-derived organoids, including pancreatic cancer models - an area traditionally challenging for in vitro culture.

This highlights its potential to accelerate personalized medicine by enabling more reliable patient-specific testing and treatment optimization.

Mitsui Chemicals continues to expand the InnoCell™ platform to address evolving needs in the life sciences sector and contribute to improved healthcare outcomes worldwide.

InnoCell™ represents Mitsui Chemicals’ commitment to advancing life sciences through material innovation, enabling researchers to unlock new possibilities in drug discovery and healthcare.

Advantages

- Replicates in vivo-like oxygen conditions

- Enables long-term stable cell culture

- Enhances reproducibility of experimental results

- Reduces reliance on animal testing through advanced in vitro models

- Supports cutting-edge research methodologies (NAMs)

These advantages make InnoCell™ a powerful tool for next-generation life science innovation.